Literature DB >> 3021206

Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin.

K Sekiguchi, A M Klos, K Kurachi, S Yoshitake, S Hakomori.   

Abstract

Human fibronectin polymorphism arises from variation in the C-terminal region [e.g., Sekiguchi, K., Siri, A., Zardi, L., & Hakomori, S. (1985) J. Biol. Chem. 260, 5105-5114]. In order to verify the chemical basis of the fibronectin polymorphism, cDNAs encoding the C-terminal region of human liver fibronectin have been isolated, sequenced, and compared with cDNAs encoding so-called "cellular fibronectin" (i.e., fibronectin produced by cultured cells in vitro). Among the five independent cDNAs thus isolated, two cDNAs, named pLF2 and pLF4, differed in the nucleotide sequence at the "type III connecting segment" (IIIcs) region. pLF4 contained 192 bases in this region whereas pLF2 completely lacked these bases. S1 mapping analysis indicated that both cDNAs with and without the 192 bases are faithful copies of two fibronectin mRNA species abundantly present in human liver. Comparison of the liver cDNAs with those coding for cellular fibronectin indicates that the latter cDNAs contain the 75-base and/or 93-base extra segments at the 5' and 3' boundaries of the 192-base IIIcs region. These extra segments have the consensus sequences for the 3' splice sites at their 3' ends, suggesting that fibronectin mRNAs with partial or complete deletion of the IIIcs sequence result from alternative splicing of a primary RNA transcript. Liver fibronectin cDNAs also lacked the 270-based "extra domain" (ED) segment present in some, but not all, cDNAs encoding cellular fibronectin. Thus, cellular fibronectin appears to have three extra peptide segments, encoded by the 75-base and 93-base segments in the IIIcs region and by the 270-base ED region, that are mostly absent in the liver fibronectin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021206     DOI: 10.1021/bi00365a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region.

Authors:  T Tressel; J B McCarthy; J Calaycay; T D Lee; K Legesse; J E Shively; H Pande
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

2.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  In vitro splicing of fibronectin pre-mRNAs.

Authors:  P A Norton; R O Hynes
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

4.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

Authors:  R P Penttinen; S Kobayashi; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Analysis of splice variants of the fibronectin gene in thyroid carcinomas by reverse transcription-polymerase chain reaction: increased expression of oncofetal fibronectin mRNA in papillary carcinomas is not caused by the alternation in splicing.

Authors:  T Takano; F Matsuzuka; G Liu; A Miyauchi; T Yokozawa; K Kuma; N Amino
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

6.  Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs.

Authors:  R P Hershberger; L A Culp
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Fibronectin binds and enhances the activity of bone morphogenetic protein 1.

Authors:  Guorui Huang; Yue Zhang; Byoungjae Kim; Gaoxiang Ge; Douglas S Annis; Deane F Mosher; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

8.  Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.

Authors:  Pamela Norton; Mary Ann Comunale; Harmin Herrera; Mengjun Wang; Josef Houser; Michaela Wimmerova; Patrick R Romano; Anand Mehta
Journal:  Proteomics       Date:  2016-11-28       Impact factor: 3.984

9.  Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature.

Authors:  M J Elices; V Tsai; D Strahl; A S Goel; V Tollefson; T Arrhenius; E A Wayner; F C Gaeta; J D Fikes; G S Firestein
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF).

Authors:  Julia Brenmoehl; Werner Falk; Michael Göke; Jürgen Schölmerich; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2008-07-17       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.